CSIMarket
 


Axonics Inc   (AXNX)
Other Ticker:  
 
 

AXNX's Free Cash Flow Growth by Quarter and Year

Axonics Inc 's Free Cash Flow results by quarter and year




AXNX Free Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 5.63 9.35 -6.78 -19.15
III Quarter September 12.34 3.85 -2.99 -12.98
II Quarter June -19.21 -0.84 -11.95 -23.31
I Quarter March -0.78 -9.17 -25.58 -28.14
FY   -2.02 3.19 -47.30 -83.58



AXNX Free Cash Flow fourth quarter 2023 Y/Y Growth Comment
Axonics Inc reported fall in Free Cash Flow in the fourth quarter 2023 by -39.79% to $ 5.63 millions, from the same quarter in 2022.
The drop in the fourth quarter 2023 Axonics Inc 's Free Cash Flow compares unfavorably to the Company's average Free Cash Flow jump of 90.53%.

Looking into fourth quarter 2023 results within Medical Equipment & Supplies industry 40 other companies have achieved higher Free Cash Flow growth. While Axonics Inc ' s Free Cash Flow drop of -39.79% ranks overall at the positon no. 1356 in the fourth quarter 2023.




AXNX Free Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December -39.79 % - - -
III Quarter September 220.52 % - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Axonics Inc 's fourth quarter 2023 Free Cash Flow $ 5.63 millions AXNX's Income Statement
Axonics Inc 's fourth quarter 2022 Free Cash Flow $ 9.35 millions Quarterly AXNX's Income Statement
New: More AXNX's historic Free Cash Flow Growth >>


AXNX Free Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December -54.38 % 142.86 % - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Free Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #41
Healthcare Sector #111
Overall #1356

Free Cash Flow Y/Y Growth Statistics
High Average Low
220.87 % 90.53 % -39.81 %
(Sep 30 2023)   (Dec 31 2023)
Free Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #41
Healthcare Sector #111
Overall #1356
Free Cash Flow Y/Y Growth Statistics
High Average Low
220.87 % 90.53 % -39.81 %
(Sep 30 2023)   (Dec 31 2023)

Free Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Axonics Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
143.12 % 44.37 % -54.39 %
(Dec 31 2022)  


AXNX's IV. Quarter Q/Q Free Cash Flow Comment
In the IV. Quarter 2023 Axonics Inc realized fall in Free Cash Flow from the third quarter by -54.38% to $ 5.63 millions, from $ 12.34 millions released in the previous quarter.

Albeit seasonal circumstance usually elevate IV. Quarter 2023 results, that simply has not been substantial to rescue Axonics Inc 's IV. Quarter outcome, Bryan Anderson, an industry insider situated in Philadelphia wrote and wrote that average quarter on quarter Free Cash Flow growth is at 44.37% for the Medical Equipment & Supplies's company.

Within Medical Equipment & Supplies industry 38 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Axonics Inc 's Free Cash Flow growth quarter on quarter, overall rank is 1192.


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #39
Healthcare Sector #100
Overall #1192
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #39
Healthcare Sector #100
Overall #1192
Free Cash Flow Q/Q Growth Statistics
High Average Low
143.12 % 44.37 % -54.39 %
(Dec 31 2022)  


AXNX's IV. Quarter Q/Q Free Cash Flow Comment
In the IV. Quarter 2023 Axonics Inc reported fall in Free Cash Flow from the third quarter by -54.38% to $ 5.63 millions, from $ 12.34 millions released a quarter before.

Those seasonal factors have not rescue the IV. Quarter for the Axonics Inc , Bryan Anderson, an industry insider situated in Philadelphia wrote, he mentioned certan skepticism conserning AXNX's outlook, he identified additional challenges onward for the Medical Equipment & Supplies's company and continued that average sequential Free Cash Flow growth is at 44.37% for the Medical Equipment & Supplies's company.

Within Medical Equipment & Supplies industry 38 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Axonics Inc 's Free Cash Flow growth quarter on quarter, overall rank is 1192.


Axonics Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Free Cash Flow 12 Months Ending $ 1.53 $ 4.29 $ -4.44 $ 14.30 $ 5.41
Y / Y Free Cash Flow Growth (TTM) -71.67 % - - - -
Year on Year Free Cash Flow Growth Overall Ranking # 1447 # 0 # 0 # 0 # 0
Seqeuential Free Cash Flow Change (TTM) -64.2 % - - 164.19 % -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # 163 # 101 # 237 # 254 # 0




Cumulative Free Cash Flow growth Comment
Axonics Inc showed decline, but improvement compare to trailing twelve month Free Cash Flow decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Axonics Inc 's annual Free Cash Flow surge would be -71.67% year on year to $2 millions.

In the Healthcare sector 109 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Free Cash Flow growth total ranking has deteriorated compare to previous quarter from 0 to 1447.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
-71.67 %
-71.67 %
-71.67 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 4
Healthcare Sector # 110
Overall # 1447

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
-71.67 %
-71.67 %
-71.67 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 8
S&P 500 # 163
Cumulative Free Cash Flow growth Comment
Axonics Inc showed decline, but improvement compare to trailing twelve month Free Cash Flow decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Axonics Inc 's annual Free Cash Flow drop would be -71.67% year on year to $2 millions.

In the Healthcare sector 109 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Free Cash Flow growth total ranking has deteriorated compare to previous quarter from 0 to 1447.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
-71.67 %
-71.67 %
-71.67 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 4
Healthcare Sector # 110
Overall # 1447

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
-71.67 %
-71.67 %
-71.67 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 8
S&P 500 # 163




Other Free Cash Flow Growth
Medical Equipment & Supplies Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
AXNX's Free Cash Flow Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for AXNX's Competitors
Free Cash Flow Growth for Axonics Inc 's Suppliers
Free Cash Flow Growth for AXNX's Customers

You may also want to know
AXNX's Annual Growth Rates AXNX's Profitability Ratios AXNX's Asset Turnover Ratio AXNX's Dividend Growth
AXNX's Roe AXNX's Valuation Ratios AXNX's Financial Strength Ratios AXNX's Dividend Payout Ratio
AXNX's Roa AXNX's Inventory Turnover Ratio AXNX's Growth Rates AXNX's Dividend Comparisons



Companies with similar Free Cash Flow drop for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Dec 31 2023
Sanofi-2.55%$ -2.546 millions
Inmode Ltd -2.62%$ -2.617 millions
Charles River Laboratories International inc -5.88%$ -5.884 millions
Mettler toledo International Inc -7.29%$ -7.291 millions
Envista Holdings Corporation-7.52%$ -7.525 millions
Bio rad Laboratories Inc -10.37%$ -10.366 millions
Inspire Medical Systems inc -10.39%$ -10.390 millions
Insulet Corporation-10.85%$ -10.848 millions
Laboratory Corporation Of America Holdings-11.32%$ -11.322 millions
Hologic Inc-13.18%$ -13.181 millions
Neurocrine Biosciences Inc -13.64%$ -13.636 millions
Gilead Sciences Inc -15.50%$ -15.504 millions
Bausch Health Companies Inc -17.89%$ -17.895 millions
Koru Medical Systems Inc-17.93%$ -17.932 millions
Progyny Inc -26.90%$ -26.900 millions
Ufp Technologies Inc -29.00%$ -28.997 millions
Enhabit Inc -29.27%$ -29.268 millions
Integra Lifesciences Holdings Corp-31.15%$ -31.153 millions
Cryoport inc -32.07%$ -32.074 millions
Qiagen N v -35.76%$ -35.764 millions
Abbvie inc -36.01%$ -36.012 millions
Regeneron Pharmaceuticals Inc -36.64%$ -36.642 millions
Pfizer Inc-38.94%$ -38.942 millions
Axonics Inc -39.81%$ -39.805 millions
Warby Parker Inc -42.68%$ -42.678 millions
Catalent Inc -47.66%$ -47.664 millions
Intuitive Surgical Inc -47.86%$ -47.865 millions
Incyte Corporation-47.92%$ -47.921 millions
Jazz Pharmaceuticals Plc-51.07%$ -51.066 millions
Edwards Lifesciences Corporation-51.70%$ -51.697 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com